The global plasmid DNA manufacturing market is probably going to grow within the estimated period thanks to the growing number of patients choosing gene therapy. as an example, as of November 2017, approximately 2,600 gene therapy clinical trials were either ongoing, completed, or approved in 36 countries, per data published by the Journal of Gene Medicine in March 2018. The countries where the tests were conducted are Kingdom of The Netherlands, Switzerland, Japan, Germany, France, China, Canada, Australia, UK, US, and others. Furthermore, diseases targeted by gene therapy count neurological diseases, eye diseases, severe combined immunodeficiency (SCID), haemophilia A and B, inflammatory and infectious diseases, cancer, cardiovascular diseases, and others.
Get Free Sample PDF Copy (Including Full TOC, List of Tables & Figures, Chart) @
The number of Kovid-19 infections is on the increase globally, resulting in fears of a shortage of life-saving equipment and other essential medical supplies to forestall the spread of the epidemic and supply optimal care to those affected. Furthermore, until pharmacological treatment is developed, ventilators function a vital treatment priority for COVID-19 patients who may require serious care. Currently, there’s an urgent have to accelerate the manufacturing process to develop a good range of test kits (antibody tests, self-administered and others).
Major players working within the market are specializing in the event of DNA vaccines for the treatment of COVID-19. In April 2020, INOVIO Pharmaceuticals Inc. German contract manufacturer Richter-Helm BioLogics GmbH & Co. to support production of INOVIO’s investigative DNA vaccine. Agreed to expand production partnership with KG, which is currently INO-4800. Phase 1 clinical trials for Covid-19 treatment within the US and Phase 2/3 efficacy tests within the summer of April 2020 could potentially move forward. Increasing government efforts to combat Kovid-19 will help speed up the epidemic. as an example, in March 2020, the US announced a US $ 2.9 million assistance package to India to assist the govt. of India develop laboratory systems, activate case detection and event-based surveillance, and assist technical experts in response and preparation. this is often a part of the US Global Aid Program to fight COVID-19.
Global Plasmid DNA Manufacturing Market: Drivers
The key players are specializing in various inorganic growth strategies like collaboration, which is probably going to drive growth within the global plasmid DNA manufacturing market over the estimated period. as an example, Biomay, CDMO, and BIA Separations, a number one bio chromatography development and manufacturing company, entered into a cooperation agreement to co-develop financial production systems in May 2018, for the assembly and refining of enormous DNA plasmids.
Request PDF Brochure with Latest Insights @
The size of the worldwide Plasmid DNA Manufacturing Market is probably going to witness a CAGR of 23.2% during the estimated period because of the adoption of inorganic growth strategies like market share of major players, the worldwide plasmid DNA manufacturing market is probably going to grow within the estimated period. as an example, in June 2017, Alma Bio Therapeutics SAS (Alma) and Delphi Genetics expanded their strategic alliance (partnership) to develop plasmid DNA drugs. Under this alliance, Delphi Genetics created plasmid DNA for the Alma Biotherapy SAS pipeline.
Depending on the kind of product, the Plasmid DNA segment is probably going to exhibit high CAGR within the global plasmid DNA manufacturing market over the estimated period. for instance, Cobra Biologics is developing pDNA for a spread of clinical applications within the UK, in keeping with world organization (EU) clinical trials guidelines. the corporate has developed its own production process for the purification and production of pDNA, including technology associated with cell-lysis technology, operator repressor titration (ORT), and antibiotic-free plasmid maintenance systems.
In terms of the event phase, pre-clinical therapeutics is probably going to dominate the worldwide plasmid DNA manufacturing market by 2021. Increased research and development activities for the event of novel plasmid DNA are likely to extend the segmentation during this estimated period. as an example, Applied DNA Sciences Inc., the leader in large-scale polymerized chain reaction-based DNA production, announced that its wholly-owned subsidiary LineaRx Inc, specializing in next-generation biotherapeutics, has begun pre-clinical development of a non-viral, plasmid. -Free (NVPF) chimeric antigen receptor (CAR) modified T lymphocyte (CAR T) production platform available to CAR-T developers worldwide in October 2018.
Among the regions, North America is probably going to dominate the worldwide plasmid DNA manufacturing market by 2021. thanks to the presence of key players within the region, North America expects significant growth in markets that specialize in expanding facilities. Production and research and development activities. as an example, VGXI Inc. has announced the launch of a novel facility to expand its bio-production services in November 2018, including space for flexible scale plasmid DNA production still as GMP production areas for RNA synthesis.
Key players performing in the Global Plasmid DNA Manufacturing Market are Geneone Life Science, Puresyn Inc., Altogen Biosystems, Genopis Inc., Synbio Technologies, Ajinomoto Bio-Pharma Services, Luina Bio Pvt Ltd, Greenpak Biotech Ltd, Lonza, GeneImmune Biotechnology Corp., Biomiga, Delphi Genetics, Cepham Life Sciences, JAFRAL Ltd., Biomay, Akron Biotech, Creative Biogene, GENEWIZ, Genscript Biotech Corporation, Luminous BioSciences (LBS) LLC, Vigene Biosciences, MeiraGTx Limited, LakePharma Inc., Waisman Biomanufacturing, Cell and Gene Therapy Catapult, PlasmidFactory GmbH & Co. KG, Nature Technology Corporation, Kaneka Corporation, Aldevron, VGXI Inc., and Cobra Biologics and Pharmaceutical Services*.
Reasons to buy this Plasmid DNA Manufacturing Market Report
◘ Save time carrying out entry-level research by identifying the size, growth, and leading players in the emerging Plasmid DNA Manufacturing Market
◘ Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the emerging Plasmid DNA Manufacturing Market
◘ Leading company profiles reveal details of key Plasmid DNA Manufacturing Market players emerging five operations and financial performance
◘ Add weight to presentations and pitches by understanding the future growth prospects of the emerging Plasmid DNA Manufacturing Market with five year historical forecasts
◘ Compares data from North America, South America, Asia Pacific Europe and Middle East Africa, alongside individual chapters on each region
𝐁𝐮𝐲 𝐓𝐡𝐢𝐬 𝐂𝐨𝐦𝐩𝐥𝐞𝐭𝐞 𝐁𝐮𝐬𝐢𝐧𝐞𝐬𝐬 𝐑𝐞𝐩𝐨𝐫𝐭 𝐖𝐢𝐭𝐡 𝐅𝐥𝐚𝐭 𝐔𝐒𝐃 𝟐𝟎𝟎𝟎 𝐎𝐟𝐟 @
Table of Content
Chapter 1 Industry Overview
1.3 Research Scope
1.4 Market Analysis by Regions
1.5 Plasmid DNA Manufacturing Market Size Analysis from 2022 to 2028
11.6 COVID-19 Outbreak: Plasmid DNA Manufacturing Industry Impact
Chapter 2 Global Plasmid DNA Manufacturing Competition by Types, Applications, and Top Regions and Countries
2.1 Global Plasmid DNA Manufacturing (Volume and Value) by Type
2.3 Global Plasmid DNA Manufacturing (Volume and Value) by Regions
Chapter 3 Production Market Analysis
3.1 Global Production Market Analysis
3.2 Regional Production Market Analysis
Chapter 4 Global Plasmid DNA Manufacturing Sales, Consumption, Export, Import by Regions
Chapter 5 North America Plasmid DNA Manufacturing Market Analysis
Chapter 6 East Asia Plasmid DNA Manufacturing Market Analysis
Chapter 7 Europe Plasmid DNA Manufacturing Market Analysis
Chapter 8 South Asia Plasmid DNA Manufacturing Market Analysis
Chapter 9 Southeast Asia Plasmid DNA Manufacturing Market Analysis
Chapter 10 Middle East Plasmid DNA Manufacturing Market Analysis
Chapter 11 Africa Plasmid DNA Manufacturing Market Analysis
Chapter 12 Oceania Plasmid DNA Manufacturing Market Analysis
Chapter 13 South America Plasmid DNA Manufacturing Market Analysis
Chapter 14 Company Profiles and Key Figures in Plasmid DNA Manufacturing Business
Chapter 15 Global Plasmid DNA Manufacturing Market Forecast (2022-2028)
Chapter 16 Conclusions
About Coherent Market Insights
Coherent Market Insights is a global market intelligence and consulting organization that provides syndicated research reports, customized research reports, and consulting services. We are known for our actionable insights and authentic reports in various domains including aerospace and defense, agriculture, food and beverages, automotive, chemicals and materials, and virtually all domains and an exhaustive list of sub-domains under the sun. We create value for clients through our highly reliable and accurate reports. We are also committed in playing a leading role in offering insights in various sectors post-COVID-19 and continue to deliver measurable, sustainable results for our clients.
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027